S07-1066

Overview

S07-1066 is an aldo-keto reductase 1C3 ( AKR1C3 ) inhibitor, synergizing doxorubicin (DOX) cytotoxicity. S07-1066 selectively blocks AKR1C3-mediated reduction of DOX, and reverses the DOX resistance in overexpressing AKR1C3 cells.

Application

Products | Products > Disease Areas > Cancer | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance

Product Information

• Catalog No.: HY-155035
• CAS No.: 876625-29-5
• Molecular Formula: C16H11Cl2FO2
• Molecular Weight: 325.16
• Purity: 99.48%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (7.69 mM); Clear solution; Need ultrasonic and warming and heat to 80°C
• Availability: In-stock

Source

Original product source